Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed. - Ferrari S; Lewiecki EM; Butler PW; Kendler DL; Napoli N; Huang S; Crittenden DB; Pannacciulli N; Siris E; Binkley N (Bone, 2020)